Glycoprotein B (gB) vaccines adjuvanted with AS01 or AS02 protect female guinea pigs against cytomegalovirus (CMV) viremia and offspring mortality in a CMV-challenge model
Mark R. Schleiss, K. Yeon Choi, Jodi Anderson, Janine Gessner Mash, Martine Wettendorff, Sally Mossman, Marc Van Damme
Dive into the research topics of 'Glycoprotein B (gB) vaccines adjuvanted with AS01 or AS02 protect female guinea pigs against cytomegalovirus (CMV) viremia and offspring mortality in a CMV-challenge model'. Together they form a unique fingerprint.